158 related articles for article (PubMed ID: 31658439)
1. Whole genome sequencing of apparently mutation-negative MEN1 patients.
Backman S; Bajic D; Crona J; Hellman P; Skogseid B; Stålberg P
Eur J Endocrinol; 2020 Jan; 182(1):35-45. PubMed ID: 31658439
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
[TBL] [Abstract][Full Text] [Related]
3. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
Uchino S; Noguchi S; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Ohshima A; Futata T; Mizukoshi T; Koike E; Takatsu K; Terao K; Wakiya S; Nagatomo M; Adachi M
Cancer Res; 2000 Oct; 60(19):5553-7. PubMed ID: 11034102
[TBL] [Abstract][Full Text] [Related]
4. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1.
Hai N; Aoki N; Shimatsu A; Mori T; Kosugi S
Clin Endocrinol (Oxf); 2000 Apr; 52(4):509-18. PubMed ID: 10762295
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Variants in MEN1: A Study Conducted with Four Multiple Endocrine Neoplasia Type 1 Patients.
Hu WM; Zhang Q; Huang LH; Mo ZH; Long XD; Yang YB; Yang WJ; Liu J; Jin P
Horm Metab Res; 2020 Nov; 52(11):788-795. PubMed ID: 32299109
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.
Pannett AA; Kennedy AM; Turner JJ; Forbes SA; Cavaco BM; Bassett JH; Cianferotti L; Harding B; Shine B; Flinter F; Maidment CG; Trembath R; Thakker RV
Clin Endocrinol (Oxf); 2003 May; 58(5):639-46. PubMed ID: 12699448
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of multiple tissues in two patients with multiple endocrine neoplasia type 1.
Naruoka A; Ohnami S; Nagashima T; Serizawa M; Hatakeyama K; Ohshima K; Ohnami S; Urakami K; Horiuchi Y; Kiyozumi Y; Matsubayashi H; Abe M; Ohishi T; Kameya T; Sugino T; Onitsuka T; Isaka M; Ohde Y; Sugiura T; Ito T; Uesaka K; Akiyama Y; Kusuhara M; Yamaguchi K
Biomed Res; 2021; 42(2):89-94. PubMed ID: 33840689
[TBL] [Abstract][Full Text] [Related]
9. True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.
Kövesdi A; Tóth M; Butz H; Szücs N; Sármán B; Pusztai P; Tőke J; Reismann P; Fáklya M; Tóth G; Somogyi A; Borka K; Erdei A; Nagy EV; Deák V; Valkusz Z; Igaz P; Patócs A; Grolmusz VK
Endocrine; 2019 Aug; 65(2):451-459. PubMed ID: 31044390
[TBL] [Abstract][Full Text] [Related]
10. Germline and somatic mosaicism in a family with multiple endocrine neoplasia type 1 (MEN1) syndrome.
Beijers HJBH; Stikkelbroeck NML; Mensenkamp AR; Pfundt R; van der Luijt RB; Timmers HJLM; Hermus ARMM; Kempers MJE
Eur J Endocrinol; 2019 Feb; 180(2):K15-K19. PubMed ID: 30481156
[TBL] [Abstract][Full Text] [Related]
11. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
Giraud S; Zhang CX; Serova-Sinilnikova O; Wautot V; Salandre J; Buisson N; Waterlot C; Bauters C; Porchet N; Aubert JP; Emy P; Cadiot G; Delemer B; Chabre O; Niccoli P; Leprat F; Duron F; Emperauger B; Cougard P; Goudet P; Sarfati E; Riou JP; Guichard S; Rodier M; Meyrier A; Caron P; Vantyghem MC; Assayag M; Peix JL; Pugeat M; Rohmer V; Vallotton M; Lenoir G; Gaudray P; Proye C; Conte-Devolx B; Chanson P; Shugart YY; Goldgar D; Murat A; Calender A
Am J Hum Genet; 1998 Aug; 63(2):455-67. PubMed ID: 9683585
[TBL] [Abstract][Full Text] [Related]
12. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
Agarwal SK; Debelenko LV; Kester MB; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Heppner C; Crabtree JS; Lubensky IA; Zhuang Z; Kim YS; Chandrasekharappa SC; Collins FS; Liotta LA; Spiegel AM; Burns AL; Emmert-Buck MR; Marx SJ
Hum Mutat; 1998; 12(2):75-82. PubMed ID: 9671267
[TBL] [Abstract][Full Text] [Related]
13. [Multiple endocrine neoplasia type 1 variants and phenocopies].
Mamedova EO; Mokrysheva NG; Przhiialkovskaia EG; Pigarova EA; Rozhinskaia LIa; Tiul'pakov AN
Ter Arkh; 2014; 86(10):87-91. PubMed ID: 25509899
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1 (MEN1): genetic and clinical analysis in the Southern Chinese.
Tso AW; Rong R; Lo CY; Tan KC; Tiu SC; Wat NM; Xu JY; Villablanca A; Larsson C; Teh BT; Lam KS
Clin Endocrinol (Oxf); 2003 Jul; 59(1):129-35. PubMed ID: 12807514
[TBL] [Abstract][Full Text] [Related]
15. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.
Haven CJ; van Puijenbroek M; Tan MH; Teh BT; Fleuren GJ; van Wezel T; Morreau H
Clin Endocrinol (Oxf); 2007 Sep; 67(3):370-6. PubMed ID: 17555500
[TBL] [Abstract][Full Text] [Related]
16. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
17. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
18. The MEN1 gene and associated diseases: an update.
Tsukada T; Yamaguchi K; Kameya T
Endocr Pathol; 2001; 12(3):259-73. PubMed ID: 11740047
[TBL] [Abstract][Full Text] [Related]
19. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients.
Romero Arenas MA; Fowler RG; San Lucas FA; Shen J; Rich TA; Grubbs EG; Lee JE; Scheet P; Perrier ND; Zhao H
Surgery; 2014 Dec; 156(6):1351-7; discussion 1357-8. PubMed ID: 25456907
[TBL] [Abstract][Full Text] [Related]
20. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
